Scientific Program
| Wednesday, 11 November 2026 | |||
| 12:00 Noon |
Registration Opens |
||
| 14:00-16:00 | Skills Workshop I: Fundamentals of Deep Brain Stimulation Programming: A practical workshop for beginners and intermediates Skills Workshop II: Skills Workshop III: |
||
| 16:00-17:15 |
Welcome to IAPRD 2026 – Opening Ceremony and Award Lectures |
||
| Congress Welcome and Invited Award Lectures • Welcome and announcements from IAPRD President, Andreas Puschmann • Announcement of Melvin Yahr Parkinson’s Disease Clinical Research Award 2026 Winner • IAPRD Melvin Yahr Lecture (selected by Awards Committee) • IAPRD Lifetime Achievement Award Lecture (selected by Awards Committee) |
|||
| 17:15-18:15 |
|
||
| Thursday, 12 November 2026 | |||
| 09:00-10:30 | General Session 1: Looking at Parkinson’s Disease With a 2026 Lens—Breaking Advances Around the Globe |
||
| 09:00-09:30 | 1a: Today’s Leading Hypotheses on How Parkinson’s Disease Begins |
||
| 09:30-10:00 | 1b: Is It or Is It Not? Diagnosing Parkinson’s Disease from Different Angles |
||
| 10:00-10:30 | 1c: Emerging Therapies That Are Likely to Make a Difference in How We Manage Parkinson’s Disease |
||
| 10:30-11:00 | Coffee Break (Exhibit and Poster Hall Open) |
||
| 11:00-12:30 | Parallel Session 1: Genetics and Environment—The Yin & Yang of Parkinson’s Disease |
Parallel Session 2: Recent Advances in Prediction and Modelling of PD Progression—Are They Ready for the Bedside? |
|
| 11:00-11:30 | 1a: Untangling the Tangled World of PD Genetics: The 2026 Update |
2a: Sticking With What We Know Best—Recognizing Motor and Non-Motor Features to Predict PD Progression |
|
| 11:30-12:00 | 1b: Spotlight on the Environmental Triggers of Parkinson’s Disease |
2b: Spotting Which PD Patient is In for a Rough Ride—Can Neuroimaging See What Our Eyes Could Not? |
|
| 12:00-12:30 | 1c: What Can We Do Now to Avoid Parkinson’s Disease? |
2c: Harnessing the Power of Technology for a Better and More Accurate Prediction of PD Progression |
|
| 12:30-14:00 | Coffee Break (Exhibit and Poster Hall Open) |
||
| 14:00-15:30 | General Session 2: The Mahlon DeLong Plenary—What Matters Most: The 2026 Therapeutics Update on Parkinson’s Disease |
||
| 14:00-14:30 | 2a: What Patients with Parkinson’s Disease Are Likely to Be Taking: Monotherapy vs Polytherapy in Parkinson’s Disease |
||
| 14:30-15:00 | 2b: Drip by Drip: Can Infusion Therapies Fill the Gap When Oral Therapies Fall Short? |
||
| 15:00-15:30 | 2c: The Very Latest on Functional Neurosurgery for Parkinson’s Disease |
||
| 15:30-16:30 |
|
Guided Poster Tours I |
|
| 16:30-18:00 | Parallel Session 3: Beneath the Parkinson’s Iceberg—Exploring Nonmotor Symptoms |
Parallel Session 4: Spotting the PD Chameleons—Update on Atypical Parkinsonism |
|
| 16:30-17:00 | 3a: The Big Two—Cognitive and Behavioral Features of Parkinson’s Disease |
4a: Surveying the Synucleinopathies in 2026 |
|
| 17:00-17:30 | 3b: No Longer a Sleeping Giant—Addressing Sleep Dysfunction in PD |
4b: Towering Over Tauopathies: Recent Advances |
|
| 17:30-18:00 | 3c: Cracking One Tough Iceberg—The Latest on Dysautonomia in PD |
4c: Here, There and Everywhere: Not To Miss Secondary Parkinsonian Disorders |
|
| 18:00-18:15 | The New IAPRD High-Low Challenge: Round 1 (Test your knowledge of recently published articles in PRD and CPRD journals – Open to ALL attendees) | ||
| Friday, 13 November 2026 | |||
| 09:00-10:30 | General Session 3: The Mark Hallett Plenary |
||
| 09:00-09:30 | 3a: Sharpening Our Clinical Lens: Incorporating the Two—Axis Classifications of Hyperkinetic Disorders |
||
| 09:30-10:00 | 3b: When Machine Wins—Using Technology in Our Approach to Hyperkinetic Disorders |
||
| 10:00-10:30 | 3c: Is Functional Neurosurgery Offering New Hope for Patients with Hyperkinetic Disorders? |
||
| 10:30-11:00 | Coffee Break (Exhibit and Poster Hall Open) |
||
| 11:00-12:30 | Parallel Session 5: Dystonia, Tics, and Chorea |
Parallel Session 6: Cerebellar Ataxias and Spastic Paraplegias |
|
| 11:00-11:30 | 5a: Navigating the Complex Map of Dystonia Genetics |
6a: Recently discovered genetic causes and optimized genetic testing in 2026 |
|
| 11:30-12:00 | 5b: Treatments and Trials in Tics and Tourette’s |
6b: Treatable Disorders: Friedreich ataxia and others |
|
| 12:00-12:30 | 5c: Synchronizing Choreography: Closing in on (non-HD) Choreas |
6c: Repeat Expansion Disorders: Molecular mechanisms and emerging therapies |
|
| 12:30-14:00 | Lunch Break (Exhibit and Poster Hall Open) |
||
| 14:00-15:30 | General Session 4: The Nir Giladi Plenary—The Heart of It All: Therapeutics in Movement Disorders |
||
| 14:00-14:30 | 4a: Hope or Hype: Update on Huntington’s Disease Treatment |
||
| 14:30-15:00 | 4b: The Ever-Expanding Universe of Botulinum Neurotoxin in Movement Disorders |
||
| 15:00-15:30 | 4c: The Formula One Approach: Neurorehabilitation in Movement Disorders |
||
| 15:30-16:30 |
|
Guided Poster Tours II |
|
| 16:30-18:00 | Parallel Session 7: Hide and Seek in Movement Disorders |
Parallel Session 8: Last Pieces of the Puzzle: Emergencies, Gait Disorders and Neuropalliative Care |
|
| 16:30-17:00 | 7a: The Masquerade Master: Attacking Autoimmune Disorders |
8a: Knowing What To Do During Movement Disorder Emergencies |
|
| 17:00-17:30 | 7b: When They Hide in Children: Pearls in Seeking Pediatric Movement Disorders |
8b: A Balancing Act: The Modern Approach to Gait Disorders |
|
| 17:30-18:00 | 7c: Spotting Zebras: New Genetic Variants and Expanding Phenotypes of Known Genetic Disorders |
8c: Developing a Neuropalliative Care Mindset |
|
| 18:00-18:15 | The New IAPRD High-Low Challenge: Round 2 (Test your knowledge of recently published articles in PRD and CPRD journals – Open to ALL attendees) | ||
| Saturday, 14 November 2026 | |||
| 08:00-09:00 |
|
Guided Poster Tours III |
|
| 09:00-10:00 | General Session 5: A Master Clinician’s Approach to Challenging Movement Disorders |
||
| 10:00-12:15 | General Session 6: IAPRD’s Grand Video Challenge—Team Innovation versus Team Collaboration |
||
| 12:15-12:30 | IAPRD 2026 Congress Awards and Closing Ceremony |
||